In the present study, we used a genetic approach to specifically eliminate myostatin activity after normal development, and we examined how this affected weight gain, muscle mass, fat mass, glucose levels and hepatic steatosis after a prolonged period of high-fat feeding. This evidence concerns the gene MSTN and fatty liver disease.